Kvaløysletta, Norway

Wenche Stensen

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 11(Granted Patents)


Location History:

  • Kvaloysletta, NO (2013 - 2019)
  • Kvaløysletta, NO (2007 - 2023)

Company Filing History:


Years Active: 2007-2023

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Wenche Stensen

Introduction

Wenche Stensen is a notable inventor based in Kvaløysletta, Norway. She has made significant contributions to the field of antimicrobial compounds and neurodegenerative disorder treatments. With a total of 10 patents to her name, her work has the potential to impact various therapeutic areas.

Latest Patents

One of her latest patents involves antimicrobial compounds, which relate to a specific formula designed to inhibit biofilm formation and remove existing biofilms. This invention includes compounds with cationic amino acids and lipophilic R groups, showcasing her innovative approach to therapy. Another significant patent focuses on benzothiazole derivatives as DYRK1 inhibitors, which are aimed at treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, as well as metabolic disorders and cancer.

Career Highlights

Throughout her career, Wenche has worked with several companies, including Lytix Biopharma AS and Peptide Patents AS. Her expertise in the field has allowed her to develop groundbreaking solutions that address critical health issues.

Collaborations

Wenche has collaborated with notable individuals in her field, including John Sigurd Svendsen and Øystein Rekdal. These partnerships have further enhanced her research and development efforts.

Conclusion

Wenche Stensen's innovative work in antimicrobial compounds and neurodegenerative disorder treatments highlights her significant contributions to science and medicine. Her patents reflect a commitment to advancing therapeutic solutions that can improve health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…